Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

🌟Dr. Tianhao Zou: A Rising Star in Hepatobiliary Oncology 🌟

Full Name: Tianhao Zou
Gender: Male
Designation: Resident Physician
Department: Department of Hepatobiliary Surgery, Center for Liver Transplantation
Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Qualification: Doctor
Area of Specialization: Hepatobiliary Oncology and Cancer
Sub Division: Oncology Therapeutics and Novel Approaches
DOB: September 10, 1997
DOJ: July 01, 2021
Total Experience: Doctor for 1 year, Master for 3 years, Bachelor for 5 years
Mobile Number: +86 18162279089
Email: zoutianhao@126.co

πŸ“š Education:

  • 2015-2020: Bachelor of Clinical Medicine, School of Medicine of Nanchang University.
  • 2020-2023: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.
  • 2023-present: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

πŸ”¬ Experience:

  • July 2021 to present: Resident Physician, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

πŸ… Research, Innovations, and Extensions:

  • No. of Research Projects Completed and Ongoing: 6
  • Citation Index: 61
  • Consultancy and Industry Sponsored Projects: 0
  • Books Published with ISBN: 0
  • Total Cost of Projects: $414,000 USD
  • Patents Published and Under Process: 5
  • Journals Published in SCI and SCIE Index: 12
  • Editorial Appointments in Journals/Conferences: 2
  • Journals Published in Scopus, Web of Science, and PubMed Index: 13
  • Countries Visited for Research Activities: 1
  • Journals Published in Other Index: 4
  • Research Scholars Graduated: 0
  • Conference Presentations: 0
  • Research Scholars Ongoing: 0
  • Cumulative Impact Factor (Last 3 Years): 55
  • Invited Speaker/Resource Person: 1
  • H-index: 5
  • Research Conferences/Workshops Organized: 0
  • Collaborative Activities for Research: 0
  • Awards and Recognition Received: 1
  • Functional MoUs with Other Universities/Industries/Corporates: 0
  • Membership in Professional Bodies: 10

🌟 Areas of Research:

  • Oncology Therapeutics and Novel Approaches

Contributions to Research & Development, Innovations, and Extension Activities:

Dr. Tianhao Zou has made substantial contributions to the field of tumor research, particularly focusing on hepatobiliary malignancies. His active participation in research projects has significantly advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. By collaborating with interdisciplinary teams, Dr. Zou has identified novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

In his innovative efforts, Dr. Zou has played a pivotal role in translating research findings into clinical practice. His collaborations with industry stakeholders, academic institutions, and healthcare providers have facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Beyond his research endeavors, Dr. Zou is committed to extension activities that promote cancer prevention, early detection, and treatment within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with essential information and resources to combat cancer effectively. Dr. Zou’s dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

πŸ”— Proof Links:

Institute ID: D202382031
Certificate (Education Proof of Last Degree): 1048732023102672
Passport/Govt. ID (Age Proof): 360425199709100212

πŸŽ–οΈSuitable Award Categories:

  • Distinguished Scientist Award
  • Young Scientist Award
  • Lifetime Achievement Award
  • Outstanding Scientist Award
  • Women Research Award
  • Best Researcher Award
  • Best Innovation Award
  • Best Faculty Award
  • Best Research Scholar Award
  • Excellence in Innovation
  • Excellence in Research
  • Excellence Award (Any Scientific Field)
  • Best Research/Innovation Extension Activity

πŸ“œβœοΈDeclaration:

I authenticate that to the best of my knowledge, the information given in this form is correct and complete. At any time I am found to have concealed any material information, my application shall be liable to be summarily terminated without notice. I have read the terms and conditions and other policies of the International Research Awards and agree to stand by the same. I agree to Pencis to process the data submitted in this application form, or any other data that the Foundation may obtain from me for any purposes connected with Pencis for any other legitimate reason.

πŸ“ŠπŸ”¬Notable Publication:

 

 

  • Title: Cell therapy for neuropathic pain
    • Authors: Yin, Q.; Zou, T.; Sun, S.; Yang, D.
    • Journal: Frontiers in Molecular Neuroscience
    • Volume: 16
    • Pages: 1119223
    • Year: 2023

 

 

Mr.Christopher Olowosoke – Targeted Cancer Therapy – Best Researcher Award

Mr.Christopher Olowosoke - Targeted Cancer Therapy - Best Researcher Award

Federal University of Technology Akure - Nigeria

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Christopher Busayo Olowosoke embarked on his academic journey with a focus on biotechnology. His dedication to academic excellence was evident during his West African Senior School Certificate Examination at Isefun Community Senior Secondary School, Lagos State, Nigeria, where he achieved a grade of Distinction in the Science stream. This early success set the stage for his future pursuits in the field of biotechnology and information technology.

PROFESSIONAL ENDEAVORS

With a passion for biotechnology and an interest in the chemistry of natural products and pharmacology, Christopher pursued his first degree at the Federal University of Technology, Akure, Ondo State, Nigeria. Graduating with an outstanding grade of 4.73/5.00 in Biotechnology in 2020, he showcased his commitment to academic excellence. His undergraduate thesis, "Identification of pungency-associated genes in some indigenous Nigerian hot pepper varieties," demonstrated his engagement with cutting-edge research.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

As a Student Research Assistant at the Federal University of Technology, Akure, Christopher actively contributed to research in the Departments of Biochemistry, Biotechnology, and Microbiology from 2017 to 2021. His involvement in in vivo, in vitro, and in silico procedures for diabetes andΒ  targeted cancer therapy underscored his commitment to addressing metabolic and cellular proliferation dysregulation, aligning with Sustainable Development Goal 3 (SDG 3). Additionally, his work on the phyto-treatment of diabetes using Andrographic paniculata showcased his dedication to innovative therapeutic approaches.

IMPACT AND INFLUENCE

Christopher's impact extended beyond the laboratory. As a Laboratory Research Assistant at Chrisland University Biotechnology Department from 2022 to the present, he played a pivotal role in organizing practical sessions and providing training in bioinformatics and molecular biology for undergraduates. His leadership as the Founder of B.Khrease Academic Consult since 2018 highlights his commitment to facilitating student projects, mentorship, and collaboration with academic experts.

ACADEMIC CITES

Christopher's research contributions are recognized through his publications. His paper titled "Multiregulator of EZH2-PPARs Therapeutic Targets" was published in Applied Biochemistry and Biotechnology in 2023. This publication addresses critical aspects of pancreatic insulin production and cancer dysregulation. The link to his full publication list on ResearchGate (https://www.researchgate.net/profile/Christopher-Olowosoke/research) reflects his ongoing scholarly pursuits.

LEGACY AND FUTURE CONTRIBUTIONS

Christopher's legacy includes leadership roles, such as being the Founder of B.Khrease Academic Consult and serving as the Promotional and Development Committee Head at the Institute of Bioinformatics and Molecular Therapeutic (IBMT) since 2021. His active participation in conferences, workshops, and professional webinars, as well as affiliations with prestigious societies, showcases his commitment to staying at the forefront of biotechnological advancements.

AWARDS/GRANT

Christopher's achievements are acknowledged through various awards and grants, including being a beneficiary of the American Society for Nutrition Early Career Professional Mentoring Program in 2023 and securing the second position in the Peeref International Best Poster Presentation in the same year. His involvement in securing the TETFUND Grant Award for the Biotechnology Department in 2022 and the UNESCO-ICB Scholarship in 2020 further demonstrates his capacity to contribute significantly to his field.

NOTABLE PUBLICATION

Multi-regulator of EZH2-PPARs Therapeutic Targets: A Hallmark for Prospective Restoration of Pancreatic Insulin Production and Cancer Dysregulation.